Group One Trading’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,895
| Closed | -$37.8K | – | 2405 |
|
|
2025
Q1 | $37.8K | Sell |
11,895
-40,873
| -77% | -$130K | ﹤0.01% | 1197 |
|
|
2024
Q4 | $282K | Buy |
52,768
+47,208
| +849% | +$253K | ﹤0.01% | 788 |
|
|
2024
Q3 | $29.4K | Buy |
+5,560
| New | +$29.4K | ﹤0.01% | 1108 |
|
|
2024
Q2 | – | Sell |
-4,604
| Closed | -$8.2K | – | 2058 |
|
|
2024
Q1 | $8.2K | Sell |
4,604
-32,060
| -87% | -$57.1K | ﹤0.01% | 1316 |
|
|
2023
Q4 | $64.5K | Buy |
36,664
+9,565
| +35% | +$16.8K | ﹤0.01% | 1013 |
|
|
2023
Q3 | $39.6K | Buy |
+27,099
| New | +$39.6K | ﹤0.01% | 1132 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2124 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2145 |
|
|
2022
Q4 | – | Sell |
-7,049
| Closed | -$6K | – | 2213 |
|
|
2022
Q3 | $6K | Sell |
7,049
-21,748
| -76% | -$18.5K | ﹤0.01% | 1662 |
|
|
2022
Q2 | $29K | Buy |
28,797
+19,722
| +217% | +$19.9K | ﹤0.01% | 1414 |
|
|
2022
Q1 | $15K | Sell |
9,075
-20,322
| -69% | -$33.6K | ﹤0.01% | 1692 |
|
|
2021
Q4 | $71K | Buy |
+29,397
| New | +$71K | ﹤0.01% | 1480 |
|
|
2021
Q3 | – | Sell |
-7,076
| Closed | -$19K | – | 2296 |
|
|
2021
Q2 | $19K | Sell |
7,076
-2,875
| -29% | -$7.72K | ﹤0.01% | 1687 |
|
|
2021
Q1 | $31K | Buy |
9,951
+4,551
| +84% | +$14.2K | ﹤0.01% | 1472 |
|
|
2020
Q4 | $19K | Buy |
5,400
+5,300
| +5,300% | +$18.6K | ﹤0.01% | 1311 |
|
|
2020
Q3 | $0 | Buy |
+100
| New | – | ﹤0.01% | 1729 |
|